Bio-Rad offers precise digital PCR system
Bio-Rad Laboratoriescontact supplier
digital PCR system
Bio-Rad has purchased Quantalife and is now offering its digital PCR (Polymerase Chain Reaction) system, which is designed to provide quantification of target molecules with precision and sensitivity.
According to the company, this next-generation PCR technology builds on the well-established method of amplifying DNA that is used in research laboratories around the world.
Digital PCR provides researchers with a new tool for the detection of rare mutations, including distinguishing rare sequences in tumours, precise measurement of copy number variation and absolute quantification of gene expression.
Researchers at Harvard Medical School and the Digital Biology Center at Bio-Rad Laboratories have developed a rapid, scalable, and cost-effective method for chromosomal phasing.
Discoveries made using Bio-Rad’s Droplet Digital PCR (ddPCR) technology were presented by researchers at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
Bio-Rad is inviting all those interested in infrared (IR) and Raman to attend its third bi-annual KnowItAll User Group Meeting at Pittcon 2015.
Bio-Rad Laboratories has launched the ddPCR KRAS Screening Multiplex Kit to its Droplet Digital PCR line of predesigned, fully wet-lab validated assays.
Cell viability assessment kit download
Bio-Rad Laboratories has announced announced VivaFix Cell Viability Assays, reagents that provide a simple way to identify dead cells in a sample.